Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373


Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis.

Zhao G, Zhou A, Lu G, Meng M, Sun M, Bai Y, Han Y, Wang L, Zhou H, Cong H, Zhao Q, Zhu XQ, He S.

Parasit Vectors. 2013 Jun 14;6:175. doi: 10.1186/1756-3305-6-175.


The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.

Zheng B, Lu S, Tong Q, Kong Q, Lou D.

Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.


Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis.

Zhao G, Zhou A, Lv G, Meng M, Sun M, Bai Y, Han Y, Wang L, Zhou H, Cong H, Zhao Q, Zhu XQ, He S.

BMC Infect Dis. 2013 May 7;13:207. doi: 10.1186/1471-2334-13-207.


Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.

Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ.

Vaccine. 2013 Mar 25;31(13):1734-9. doi: 10.1016/j.vaccine.2013.01.027. Epub 2013 Jan 29.


Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.

Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, Zhou H, He S.

Parasit Vectors. 2013 Mar 13;6:63. doi: 10.1186/1756-3305-6-63.


Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.

Cao A, Liu Y, Wang J, Li X, Wang S, Zhao Q, Cong H, He S, Zhou H.

Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.


Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.

Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H.

Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.


Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.

Cui X, Lei T, Yang D, Hao P, Li B, Liu Q.

Vaccine. 2012 Mar 16;30(13):2282-7. doi: 10.1016/j.vaccine.2012.01.073. Epub 2012 Feb 3.


DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.

Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ.

Vaccine. 2013 Dec 16;31(52):6225-31. doi: 10.1016/j.vaccine.2013.10.034. Epub 2013 Oct 31.


Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice.

Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, Li HX, Lv ZC, Cheng T, Ren D, Yang GL, Lin RQ, Zhu XQ.

Clin Vaccine Immunol. 2012 Dec;19(12):1916-20. doi: 10.1128/CVI.00397-12. Epub 2012 Sep 26.


Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.

Chen J, Zhou DH, Li ZY, Petersen E, Huang SY, Song HQ, Zhu XQ.

Exp Parasitol. 2014 Apr;139:42-8. doi: 10.1016/j.exppara.2014.02.016. Epub 2014 Mar 3.


DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.

Zhang M, Zhao L, Song J, Li Y, Zhao Q, He S, Cong H.

Vaccine. 2013 Sep 23;31(41):4536-40. doi: 10.1016/j.vaccine.2013.07.065. Epub 2013 Aug 6.


Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.

Wang HL, Li YQ, Yin LT, Meng XL, Guo M, Zhang JH, Liu HL, Liu JJ, Yin GR.

PLoS One. 2013 Aug 15;8(8):e70884. doi: 10.1371/journal.pone.0070884. eCollection 2013.


DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice.

Sun XM, Zou J, A A ES, Yan WC, Liu XY, Suo X, Wang H, Chen QJ.

Parasit Vectors. 2011 Nov 9;4:213. doi: 10.1186/1756-3305-4-213.


Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii.

Quan JH, Chu JQ, Ismail HA, Zhou W, Jo EK, Cha GH, Lee YH.

Clin Vaccine Immunol. 2012 May;19(5):666-74. doi: 10.1128/CVI.05385-11. Epub 2012 Mar 14.


Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.

Xue M, He S, Cui Y, Yao Y, Wang H.

Parasitol Int. 2008 Dec;57(4):424-9. doi: 10.1016/j.parint.2008.05.001. Epub 2008 May 16.


Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.

Qu D, Wang S, Cai W, Du A.

Vaccine. 2008 Aug 18;26(35):4541-8. doi: 10.1016/j.vaccine.2008.06.030. Epub 2008 Jun 30.


Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.

Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35.


Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.

Nielsen HV, Lauemøller SL, Christiansen L, Buus S, Fomsgaard A, Petersen E.

Infect Immun. 1999 Dec;67(12):6358-63.


A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.

Yin H, Zhao L, Wang T, Zhou H, He S, Cong H.

Parasit Vectors. 2015 Sep 30;8:498. doi: 10.1186/s13071-015-1108-7.

Supplemental Content

Support Center